Genetically predicted alkaline phosphatase remained nominally significantly associated with overall breast cancer liability after adjusting for testosterone and SHBG in MVMR (OR: 0.94, 95% CI: 0.89–0.98) (Additional file 4: Fig. S9). The gene discussed is SHBG; the disease is breast cancer.